Literature DB >> 17287271

Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection.

Mathias Lichterfeld1, Xu G Yu, Stanley K Mui, Katie L Williams, Alicja Trocha, Mark A Brockman, Rachel L Allgaier, Michael T Waring, Tomohiko Koibuchi, Mary N Johnston, Daniel Cohen, Todd M Allen, Eric S Rosenberg, Bruce D Walker, Marcus Altfeld.   

Abstract

Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells in early infection are associated with the dramatic decline of peak viremia, whereas their antiviral activity in chronic infection is less apparent. The functional properties accounting for the antiviral activity of HIV-1-specific CD8+ T cells during early infection are unclear. Using cytokine secretion and tetramer decay assays, we demonstrated in intraindividual comparisons that the functional avidity of HIV-1-specific CD8+ T cells was consistently higher in early infection than in chronic infection in the presence of high-level viral replication. This change of HIV-1-specific CD8+ T-cell avidity between early and chronic infections was linked to a substantial switch in the clonotypic composition of epitope-specific CD8+ T cells, resulting from the preferential loss of high-avidity CD8+ T-cell clones. In contrast, the maintenance of the initially recruited clonotypic pattern of HIV-1-specific CD8+ T cells was associated with low-level set point HIV-1 viremia. These data suggest that high-avidity HIV-1-specific CD8+ T-cell clones are recruited during early infection but are subsequently lost in the presence of persistent high-level viral replication.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17287271      PMCID: PMC1866095          DOI: 10.1128/JVI.01388-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection.

Authors:  M Dalod; M Dupuis; J C Deschemin; C Goujard; C Deveau; L Meyer; N Ngo; C Rouzioux; J G Guillet; J F Delfraissy; M Sinet; A Venet
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

2.  Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?

Authors:  Thorsten U Vogel; Thomas C Friedrich; David H O'Connor; William Rehrauer; Elizabeth J Dodds; Heather Hickman; William Hildebrand; John Sidney; Alessandro Sette; Austin Hughes; Helen Horton; Kathy Vielhuber; Richard Rudersdorf; Ivna P De Souza; Matthew R Reynolds; Todd M Allen; Nancy Wilson; David I Watkins
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes.

Authors:  A Oxenius; D A Price; P J Easterbrook; C A O'Callaghan; A D Kelleher; J A Whelan; G Sontag; A K Sewell; R E Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

4.  Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection.

Authors:  J D Wilson; G S Ogg; R L Allen; C Davis; S Shaunak; J Downie; W Dyer; C Workman; S Sullivan; A J McMichael; S L Rowland-Jones
Journal:  AIDS       Date:  2000-02-18       Impact factor: 4.177

5.  Caveats in the design of MHC class I tetramer/antigen-specific T lymphocytes dissociation assays.

Authors:  Xiaochi L Wang; John D Altman
Journal:  J Immunol Methods       Date:  2003-09       Impact factor: 2.303

6.  Evolution of CD8+ T cell immunity and viral escape following acute HIV-1 infection.

Authors:  Jianhong Cao; John McNevin; Uma Malhotra; M Juliana McElrath
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

7.  Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection.

Authors:  Jianhong Cao; John McNevin; Sarah Holte; Lisa Fink; Lawrence Corey; M Juliana McElrath
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

8.  Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection.

Authors:  R Draenert; C L Verrill; Y Tang; T M Allen; A G Wurcel; M Boczanowski; A Lechner; A Y Kim; T Suscovich; N V Brown; M M Addo; B D Walker
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

9.  Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.

Authors:  Susan M Kaech; Joyce T Tan; E John Wherry; Bogumila T Konieczny; Charles D Surh; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-11-16       Impact factor: 25.606

10.  HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity.

Authors:  Souheil-Antoine Younes; Bader Yassine-Diab; Alain R Dumont; Mohamed-Rachid Boulassel; Zvi Grossman; Jean-Pierre Routy; Rafick-Pierre Sekaly
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  58 in total

1.  Antiretroviral therapy reduces the magnitude and T cell receptor repertoire diversity of HIV-specific T cell responses without changing T cell clonotype dominance.

Authors:  Joseph A Conrad; Ramesh K Ramalingam; Coley B Duncan; Rita M Smith; Jie Wei; Louise Barnett; Brenna C Simons; Shelly L Lorey; Spyros A Kalams
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

2.  Clonal expansion and TCR-independent differentiation shape the HIV-specific CD8+ effector-memory T-cell repertoire in vivo.

Authors:  Dirk Meyer-Olson; Brenna C Simons; Joseph A Conrad; Rita M Smith; Louise Barnett; Shelly L Lorey; Coley B Duncan; Ramesh Ramalingam; Spyros A Kalams
Journal:  Blood       Date:  2010-04-27       Impact factor: 22.113

3.  Changes in function of HIV-specific T-cell responses with increasing time from infection.

Authors:  Michel L Ndongala; Philomena Kamya; Salix Boulet; Yoav Peretz; Danielle Rouleau; Cécile Tremblay; Roger Leblanc; Pierre Côté; Jean-Guy Baril; RéJean Thomas; Sylvie Vézina; Mohamed R Boulassel; Jean-Pierre Routy; Rafick P Sékaly; Nicole F Bernard
Journal:  Viral Immunol       Date:  2010-04       Impact factor: 2.257

4.  CD4 T-cell regeneration in HIV-1 elite controllers.

Authors:  Yue Yang; Maha Al-Mozaini; Maria J Buzon; Jill Beamon; Sara Ferrando-Martinez; Ezequiel Ruiz-Mateos; Eric S Rosenberg; Florencia Pereyra; Xu G Yu; Mathias Lichterfeld
Journal:  AIDS       Date:  2012-03-27       Impact factor: 4.177

Review 5.  Translating insights from persistent LCMV infection into anti-HIV immunity.

Authors:  Elizabeth B Wilson; David G Brooks
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

6.  Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity.

Authors:  Jorge R Almeida; Delphine Sauce; David A Price; Laura Papagno; So Youn Shin; Arnaud Moris; Martin Larsen; Gianfranco Pancino; Daniel C Douek; Brigitte Autran; Asier Sáez-Cirión; Victor Appay
Journal:  Blood       Date:  2009-04-23       Impact factor: 22.113

7.  Telomerase activity of HIV-1-specific CD8+ T cells: constitutive up-regulation in controllers and selective increase by blockade of PD ligand 1 in progressors.

Authors:  Mathias Lichterfeld; Danlei Mou; Thai Duong Hong Cung; Katie L Williams; Michael T Waring; Jinghe Huang; Florencia Pereyra; Alicja Trocha; Gordon J Freeman; Eric S Rosenberg; Bruce D Walker; Xu G Yu
Journal:  Blood       Date:  2008-08-26       Impact factor: 22.113

8.  Both HLA-B*57 and plasma HIV RNA levels contribute to the HIV-specific CD8+ T cell response in HIV controllers.

Authors:  Camille Lécuroux; Asier Sáez-Cirión; Isabelle Girault; Pierre Versmisse; Faroudy Boufassa; Véronique Avettand-Fenoël; Christine Rouzioux; Laurence Meyer; Gianfranco Pancino; Olivier Lambotte; Martine Sinet; Alain Venet
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

Review 9.  Innate and Adaptive Immune Regulation During Chronic Viral Infections.

Authors:  Elina I Zuniga; Monica Macal; Gavin M Lewis; James A Harker
Journal:  Annu Rev Virol       Date:  2015-09-02       Impact factor: 10.431

10.  HIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity.

Authors:  Benoît Vingert; Santiago Perez-Patrigeon; Patricia Jeannin; Olivier Lambotte; Faroudy Boufassa; Fabrice Lemaître; William W Kwok; Ioannis Theodorou; Jean-François Delfraissy; Jacques Thèze; Lisa A Chakrabarti
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.